De novo diabetes és májátültetés, különös tekintettel a hepatitis C-vírus kiújulására

Translated title of the contribution: New-onset diabetes mellitus after liver transplantation

B. Nemes, Fanni Gelley, Gergely Zádori, Katalin Földes, G. Firneisz, Dénes Görög, Imre Fehérvári, L. Kóbori, Zsuzsanna Gerlei, János Fazakas, Simon Pápai, Attila Doros, P. Nagy, G. Lengyel, Z. Schaff, E. Sárváry

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

New-onset diabetes is a common complication after liver transplantation. Aim: We aimed to analyze the incidence and rate of known risk factors and the impact of new-onset diabetes mellitus on postoperative outcome. Methods: We retrospectively evaluated the files of 310 patients who underwent liver transplantation between 1995 and 2009. Definition of new-onset diabetes included: repeated fasting serum glucose >6.8 mmol/l and/or sustained antidiabetic therapy that was present 3 months after transplantation. Results: New-onset diabetes occurred in 63 patients (20%). Differences between the new-onset and the control group were the donor body mass index (24±3 vs. 22.4±3.6 kg/m2, p = 0.003), donor male gender (58% vs. 33%, p = 0.002), and recipient age (47.6±7.2 vs. 38.3±14.6 year, p2, p

Original languageHungarian
Pages (from-to)1062-1071
Number of pages10
JournalOrvosi Hetilap
Volume151
Issue number26
DOIs
Publication statusPublished - Jun 1 2010

Fingerprint

Liver Transplantation
Diabetes Mellitus
Tissue Donors
Hypoglycemic Agents
Fasting
Body Mass Index
Transplantation
Glucose
Control Groups
Incidence
Serum
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

De novo diabetes és májátültetés, különös tekintettel a hepatitis C-vírus kiújulására. / Nemes, B.; Gelley, Fanni; Zádori, Gergely; Földes, Katalin; Firneisz, G.; Görög, Dénes; Fehérvári, Imre; Kóbori, L.; Gerlei, Zsuzsanna; Fazakas, János; Pápai, Simon; Doros, Attila; Nagy, P.; Lengyel, G.; Schaff, Z.; Sárváry, E.

In: Orvosi Hetilap, Vol. 151, No. 26, 01.06.2010, p. 1062-1071.

Research output: Contribution to journalArticle

Nemes, B, Gelley, F, Zádori, G, Földes, K, Firneisz, G, Görög, D, Fehérvári, I, Kóbori, L, Gerlei, Z, Fazakas, J, Pápai, S, Doros, A, Nagy, P, Lengyel, G, Schaff, Z & Sárváry, E 2010, 'De novo diabetes és májátültetés, különös tekintettel a hepatitis C-vírus kiújulására', Orvosi Hetilap, vol. 151, no. 26, pp. 1062-1071. https://doi.org/10.1556/OH.2010.28902
Nemes, B. ; Gelley, Fanni ; Zádori, Gergely ; Földes, Katalin ; Firneisz, G. ; Görög, Dénes ; Fehérvári, Imre ; Kóbori, L. ; Gerlei, Zsuzsanna ; Fazakas, János ; Pápai, Simon ; Doros, Attila ; Nagy, P. ; Lengyel, G. ; Schaff, Z. ; Sárváry, E. / De novo diabetes és májátültetés, különös tekintettel a hepatitis C-vírus kiújulására. In: Orvosi Hetilap. 2010 ; Vol. 151, No. 26. pp. 1062-1071.
@article{e0ade8113aad4f0f94864228ee10bf02,
title = "De novo diabetes {\'e}s m{\'a}j{\'a}t{\"u}ltet{\'e}s, k{\"u}l{\"o}n{\"o}s tekintettel a hepatitis C-v{\'i}rus ki{\'u}jul{\'a}s{\'a}ra",
abstract = "New-onset diabetes is a common complication after liver transplantation. Aim: We aimed to analyze the incidence and rate of known risk factors and the impact of new-onset diabetes mellitus on postoperative outcome. Methods: We retrospectively evaluated the files of 310 patients who underwent liver transplantation between 1995 and 2009. Definition of new-onset diabetes included: repeated fasting serum glucose >6.8 mmol/l and/or sustained antidiabetic therapy that was present 3 months after transplantation. Results: New-onset diabetes occurred in 63 patients (20{\%}). Differences between the new-onset and the control group were the donor body mass index (24±3 vs. 22.4±3.6 kg/m2, p = 0.003), donor male gender (58{\%} vs. 33{\%}, p = 0.002), and recipient age (47.6±7.2 vs. 38.3±14.6 year, p2, p",
keywords = "hepatitis C virus, liver transplantation, new-onset diabetes, recurrence",
author = "B. Nemes and Fanni Gelley and Gergely Z{\'a}dori and Katalin F{\"o}ldes and G. Firneisz and D{\'e}nes G{\"o}r{\"o}g and Imre Feh{\'e}rv{\'a}ri and L. K{\'o}bori and Zsuzsanna Gerlei and J{\'a}nos Fazakas and Simon P{\'a}pai and Attila Doros and P. Nagy and G. Lengyel and Z. Schaff and E. S{\'a}rv{\'a}ry",
year = "2010",
month = "6",
day = "1",
doi = "10.1556/OH.2010.28902",
language = "Hungarian",
volume = "151",
pages = "1062--1071",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "26",

}

TY - JOUR

T1 - De novo diabetes és májátültetés, különös tekintettel a hepatitis C-vírus kiújulására

AU - Nemes, B.

AU - Gelley, Fanni

AU - Zádori, Gergely

AU - Földes, Katalin

AU - Firneisz, G.

AU - Görög, Dénes

AU - Fehérvári, Imre

AU - Kóbori, L.

AU - Gerlei, Zsuzsanna

AU - Fazakas, János

AU - Pápai, Simon

AU - Doros, Attila

AU - Nagy, P.

AU - Lengyel, G.

AU - Schaff, Z.

AU - Sárváry, E.

PY - 2010/6/1

Y1 - 2010/6/1

N2 - New-onset diabetes is a common complication after liver transplantation. Aim: We aimed to analyze the incidence and rate of known risk factors and the impact of new-onset diabetes mellitus on postoperative outcome. Methods: We retrospectively evaluated the files of 310 patients who underwent liver transplantation between 1995 and 2009. Definition of new-onset diabetes included: repeated fasting serum glucose >6.8 mmol/l and/or sustained antidiabetic therapy that was present 3 months after transplantation. Results: New-onset diabetes occurred in 63 patients (20%). Differences between the new-onset and the control group were the donor body mass index (24±3 vs. 22.4±3.6 kg/m2, p = 0.003), donor male gender (58% vs. 33%, p = 0.002), and recipient age (47.6±7.2 vs. 38.3±14.6 year, p2, p

AB - New-onset diabetes is a common complication after liver transplantation. Aim: We aimed to analyze the incidence and rate of known risk factors and the impact of new-onset diabetes mellitus on postoperative outcome. Methods: We retrospectively evaluated the files of 310 patients who underwent liver transplantation between 1995 and 2009. Definition of new-onset diabetes included: repeated fasting serum glucose >6.8 mmol/l and/or sustained antidiabetic therapy that was present 3 months after transplantation. Results: New-onset diabetes occurred in 63 patients (20%). Differences between the new-onset and the control group were the donor body mass index (24±3 vs. 22.4±3.6 kg/m2, p = 0.003), donor male gender (58% vs. 33%, p = 0.002), and recipient age (47.6±7.2 vs. 38.3±14.6 year, p2, p

KW - hepatitis C virus

KW - liver transplantation

KW - new-onset diabetes

KW - recurrence

UR - http://www.scopus.com/inward/record.url?scp=77953829705&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953829705&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28902

DO - 10.1556/OH.2010.28902

M3 - Article

C2 - 20558353

AN - SCOPUS:77953829705

VL - 151

SP - 1062

EP - 1071

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 26

ER -